Hormel Foods Corp. (HRL) is getting out of the whole-bird turkey business, and the move says a lot about where the company thinks it can actually make money. On Tuesday, Hormel announced a deal to sell that operation to Life-Science Innovations while simultaneously releasing preliminary first-quarter fiscal 2026 results that show modest but steady progress.
The headline numbers look decent enough. Hormel is projecting net sales around $3 billion for the quarter with 2% organic growth. That's a hair below what analysts were expecting at $3.07 billion, but adjusted earnings per share of 34 cents came in above the 32-cent consensus estimate. Not exactly fireworks, but not bad either.
Why Hormel Is Saying Goodbye to Whole Turkeys
The turkey divestment is the more interesting part of this story. Hormel is essentially admitting that selling whole birds at Thanksgiving is a commodity business with volatile margins, and it would rather focus on higher-value products where brand and processing add more consistent profitability. Think turkey bacon, deli slices, and prepared items rather than the 20-pound frozen bird your uncle argues about carving every November.
Life-Science Innovations is buying Hormel's production and transportation assets in Minnesota, including the Melrose whole-bird facility and the Swanville feed mill. LSI will also take over supply agreements with independent turkey growers and handle co-manufacturing operations with Hormel through the end of fiscal 2026 to keep everything running smoothly during the transition. The deal is expected to close by the end of Hormel's second fiscal quarter.
"This transaction is an important next step in our evolution. With a more focused turkey portfolio, we will continue strengthening the value-added aspects of our JENNIE-O business. We look forward to working with LSI to ensure a smooth transition for our team members, customers, consumers, and suppliers," said John Ghingo, president of Hormel Foods.
The JENNIE-O brand isn't going anywhere. It remains a significant revenue driver for Hormel, but now the company gets to concentrate on the parts of that brand that deliver better margins and less exposure to commodity price swings.
What the Numbers Tell Us
Hormel's first-quarter guidance shows diluted earnings per share of 33 cents, with adjusted earnings hitting 34 cents. That modest beat over analyst expectations suggests the company's operational improvements are starting to gain traction, even if top-line growth remains subdued.
Interim CEO Jeff Ettinger sounded cautiously optimistic about the direction. "They reflect a solid start to the year, are aligned with our expectations and give us confidence that we are focused on the right initiatives to return Hormel Foods to profitable growth," he said.
The company expects minimal impact on its adjusted fiscal 2026 financial results from the turkey business sale, which makes sense since they're exiting a lower-margin operation. At the upcoming Consumer Analyst Group of New York conference, Hormel plans to reaffirm its fiscal 2026 guidance targeting 2-3% organic net sales growth and 5-7% operating profit growth. The higher operating profit growth relative to sales growth is the whole point here—better margins through a more focused product mix.
Ettinger, who's steering the ship in the interim CEO role, emphasized that the first-quarter results met expectations and validated the company's commitment to profitable growth. By shedding commodity-driven segments like whole-bird turkeys, Hormel aims to reduce volatility and build a more predictable earnings profile.
Hormel shares were trading up 0.81% at $23.63 during premarket trading on Wednesday, hovering near their 52-week lows as investors digest the strategic repositioning.
